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The rapid development of the chemical industry, combustion of fossil fuels, and smoking of tobacco
have resulted in contact of the general population with benzo(a)pyrene and other carcinogenic aromatic
hydrocarbons. Persons especially at risk occupationally are those engaged in thermal processing of oil
shale, coal, and heavy residual petroleum.
It has been shown that polycyclic aromatic hydrocarbons require metabolic activation before they can
act as mutagens or carcinogens. This metabolic activation results from interaction with microsomal
enzymes present in many body cells, yielding reactive epoxides which react with DNA and produce
mutations in the count frame shift or participate in covalent bonding. While opinions differ regarding the
relative role of these processes in mutagenesis, considerable evidence exists which links mutagenesis and
carcinogenesis.
Metabolites of the polycyclic aromatic hydrocarbons which are carcinogenic are usually mutagenic,
which supports the hypothesis that damage to chromosomes plays an important role in carcinogenesis.
These facts open the possibility to monitoring the spread ofcarcinogenic substances in the biosphere by
relatively simple tests whose endpoint is mutagenesis.
The rapid development of the modern chemical
industry has resulted in the introduction of a large
number of polycyclic aromatic hydrocarbons into
the environment. These substances have been de-
tected in air, soil, reservoir water, marine sedi-
ments, and in some types of food products.
Production processes related to heat treatment
and incomplete fuel combustion of combustible
shale in particular serve as the primary sources of
environmental pollution by polycyclic aromatic hy-
drocarbons.
Eleven carcinogenic polycyclic aromatic hy-
drocarbons were detected in the air of industrial
cities (1, 2). These substances are released into the
environment in the exhaust gases of internal com-
bustion engines, in various types of smoke, in the
smoke from tobacco, and in fly ash. The most wide-
spread ofthese is benz(a)pyrene. Fly ash from coke
contains 0.2,gbenz(a)pyrene pergram ofcoke ash,
from 7.5 to 9.2 Ag benz(a)pyrene per gram of coal
ash, 1.4 to 1.5 ,ug benz(a)pyrene per gram ofbrown
coal ash, and 11.5 to 20.1 ,ug of benz(a)pyrene per
gram of wood ash (3). Benz(a)pyrene is also found
in various tars which are dumped into water reser-
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voirs with wastewater from chemical or petroleum
processing and wastes from the coal tar chemical
and shale industries (4). The following amounts of
benz(a)pyrene were detected in the wastewater of
the following industrial enterprises: coal-tar chemi-
cal enterprises, 0.092-2.65 mg/l. (5); petroleum pro-
cessing enterprises, 0.58-0.181 ,g/l. (6); production
ofacetylene, 0.061 mg/l. (7). It should be stated that
the wastewater treatment facilities did not remove
benz(a)pyrene.
Since benz(a)pyrene is frequently found in
drinking water, the World Health Organization has
established that its concentration should not exceed
0.2 ug/l. (8).
A large number of people in industry come into
contact with products containing polycyclic aro-
matic hydrocarbons in the following forms: workers
at enterprises which thermally process combustible
shales, hard coal, petroleum and also at enterprises
utilizing products from the thermal processing of
fuels (hard coal, pitch, tars, bitumins and oils, shale
tarand oils, certain types ofpetroleum and products
obtained from processing pitch, residual heavy oil,
bitumins and oil of petroleum origin), along with
products from the wood chemical industry and the
processing of peat. As a consequence, it has been
established that benz(a)pyrene is contained at a
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1.5-2% in coal pitch, and 0.2% in shale tars, par-
ticularly of the Kamara type (9). Other hy-
drocarbons are also found in the majority of the
above industrial products, but at lower concentra-
tions.
Polycyclic aromatic hydrocarbons represent a
danger due to their potential carcinogenic and
mutagenic capabilities. It has been shown that ap-
proximately 90Wo of the cancer occurring in man is
of chemical origin (10). Data exist which indicate
that 60-80% of various forms of cancer in man are
the result ofthe effect ofthe environment (Il , 12). It
is probable that polycyclic aromatic hydrocarbons
make their contributions in this respect.
There have been a significant number of studies
to investigate the mechanism responsible for the
mutagenic effect of polycyclic aromatic hy-
drocarbons in in vitro test systems and their capac-
ity for malignant transformation ofmammalian cells
in in vitro-in vivo tests and to determine the car-
cinogenic potential ofthese compounds for animals
in vlvo.
It was shown that polycyclic aromatic hy-
drocarbons are among those compounds which by
themselves are neither active mutagenic agents nor
active carcinogens, but only after transformation
through the mammalian metabolism are they con-
verted into chemically reactive derivatives which
damage genetic material and evoke malignant
changes in cells. It is shown that the potentially
carcinogenic polycyclic aromatic hydrocarbons
manifest their mutagenic properties after activation
by microsomal liver enzymes in mammals (13-18).
Later it turned out that the activating capacity is not
possessed solely by liver enzymes but also by the
enzymes ofother organism tissue, such as lung (19,
20), along with the epithelial bronchial cells in man
(21).
Many studies have concerned the problem ofhow
polycyclic aromatic hydrocarbons are metabolized
in the mammalian organism. It is shown that
polycyclic aromatic hydrocarbons are metabolized
into epoxides (13, 22-24). Epoxides couple with
nucleic acids to a greater extent than do the corre-
sponding hydrocarbons. It is on this basis that their
significant activity in inducing malignant transfor-
mation can be explained (23). It is supposed (25)
that the metabolic transformation of polycyclic ar-
omatic hydrocarbons is necessary for the covalent
bond formation of their metabolites with DNA,
RNA, and albumins.
Cavalieri and Calvin (26) proposed the effect of
enzymes served as the mechanism for activating
polycyclic aromatic hydrocarbons. Results from a
study of the reactivity at various points of the ring
system ofthe three strongest hydrocarbon carcino-
gens, i.e., benz(a)pyrene, 7,12-dimethylbenzo-
anthracene, and 3-methylcholanthrene, showed the
most reactive positions to be those at which the
proton is replaced easily. It is most likely that the
bonds with nucleic acids are formed at these posi-
tions.
Studies concerned with the degree of hy-
drocarbon bonding with macromolecules relate to
the establishment of a relationship between the
number of bonds and the level of cellular metab-
olism, the carcinogenic activity of the chemical
compound, the state of DNA, and other aspects. A
positive correlation has been established between
the cellular metabolic activity and the bonding di-
mension of the polycyclic aromatic hydrocarbons
with DNA (27). The highest number ofbonds noted
for DNA was observed for DNA which was ob-
tained from cells with high metabolism (28).
Quantitative studies were also undertaken to in-
vestigate the bonding of polycyclic aromatic hy-
drocarbons which differ with respect to their degree
ofcarcinogenicity with DNA, RNA, and albumin. A
positive correlation was established between the
carcinogenic activity of chemical substances and
the number of bonds with macromolecules (29-31).
This correlation was considered as a bond between
the hydrocarbon molecules and the macromolecule
at a dosage of I inM of hydrocarbon/mouse. It
turned out that the bonding level with polycyclic
aromatic hydrocarbons is characteristically greater
for DNA than for protein or RNA. For agiven dose,
it took 0.1-1.0 molecules of hydrocarbon/molecule
of DNA while it took 0.01-0.02 molecules in the
case of protein. In studying the interaction of di-
methylbenzanthracene (DMBA) at various concen-
trations with normal cages of rodents (32) it was
also established that the highest activity in bonding
hydrocarbon is inherent to DNA. At doses of
0.01-0.1 mg/ml, the number ofbonds with RNA was
two times less and with proteins four times less than
with DNA. At the highest possible saturated con-
centrations of DMBA, the bonds were equivalent to
one molecule of hydrocarbon/molecule of DNA,
while in the case of protein, the ratio was one
molecule ofhydrocarbon/1250 molecules ofprotein.
Besides the capacity to form covalent bonds,
another mechanism was determined for the interac-
tion with DNA. Epoxides can be physically situated
in the DNA molecule (13, 22, 33-35). This appears
to be the reason for the insertions in the replication
process and in the repair synthesis of DNA. Obvi-
ously shift stabilization ofthe repeating sequence of
bases is observed. The effectiveness ofthe building
agent as one which has shifted the mutagen count
framework declines, if this agent is capable of
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ity to be incorporated in the molecule can be fixed
by this covalent reaction.
Studies have also been undertaken concerned
with the malignant transformation of mammalian
cells in vitro under the effect of hydrocarbons. In
treating the cell cultures of mouse prostate gland
with various polycyclic aromatic hydrocarbons,
such malignant transformation were observed as the
formation of multilayer cultures with chaotic cell
orientation, the manifestation of cells with mul-
tipolar mitoses, increase in the capacity of cells to
stick to glass, and their increased sensitivity to heat.
On transplantation of such cells in animals, the lat-
ter as a rule develop tumors (36-40).
In studying the quantitative aspects of malignant
transformations after treating the cell cultures of
mice with carcinogenic and noncarcinogenic hy-
drocarbons, a clear correlation was observed be-
tween the carcinogenic activity ofthe polycyclic ar-
omatic hydrocarbons and the transformation fre-
quency. Powerful carcinogens conditioned the
maximum frequency oftransformations, while non-
carcinogenic polycyclic aromatic hydrocarbons did
not produce transformed cell colonies (38, 41).
As a consequence, DNA, RNA, and proteins
serve as the primary targets for carcinogenic hy-
drocarbons. Reactive epoxides are formed in the
mammalian organism. These reactive epoxides are
obviously those terminal forms on which malignant
transformation of cells depend. The epoxides can
react with fundamental DNA and RNA and also
build themselves in between the bases of DNA,
evoking mutations in the count frame shift.
It was shown that DNA in the most sensitive re-
ceptor for polycyclic aromatic hydrocarbons, RNA
and proteins being less sensitive. This corresponds
to the mutation theory ofcarcinogenesis. In dealing
with the problem as to which ofthe two processes,
i.e., the formation of the covalent bonds or the lo-
cation (intercalation), is of greater significance in
carcinogenesis, the first process is considered by a
number of authors to be the most important factor
in the biological phenomena of carcinogenesis and
mutagenesis (27, 42), while other authors (14, 16)
show that carcinogenic polycyclic aromatic hy-
drocarbons manifest themselves in test strains
which have been designated for determining muta-
gens, shifting the count frame and that it is primarily
the intercalation ofhydrocarbons between the DNA
bases which is the reason for carcinogenesis, while
the covalent bonds intensify the carcinogenic po-
tential of the chemical compound.
It has been hypothesized that the manifestation of
mutations in somatic cells may be the reason for
carcinogenesis (43-45). It was also shown that the
terminal metabolites of many carcinogens (includ-
ing those of polycyclic aromatic hydrocarbons) are
mutagens (46). The parallel effect of the mutagenic
and carcinogenic action of hydrocarbons was noted
by Avertsev (47) and Fridlyanskaya (48), who
showed the carcinogenic polycyclic aromatic hy-
drocarbons evoke chromosomal aberrations in a rat
cell culture, while their noncarcinogenic analogs do
not have an effect from a practical point of view on
chromosome mutation frequency. On the basis of
these studies, the authors conclude that mutations
participate in carcinogenesis.
In studying the quantitative relationship between
the carcinogenic and mutagenic properties of
polycyclic aromatic hydrocarbons, a parallel ef-
fect was found between the ability of 12-benzo-
anthracene derivatives to damage the chromo-
somes of bone marrow cells and the ability to
cause sarcoma when rats were injected with
these substances (49). The results of the work
clearly show the quantitative correlation and make
it possible to suppose that damage to chromosomes
plays an important role in carcinogenesis. In addi-
tion, Teranishi et al. (17) used the Iball index (50) to
evaluate the carcinogenicity of polycyclic aromatic
hydrocarbons in polluted air. Their mutagenic po-
tential was studied on Salmonella by using the pro-
cedure of Ames et al. (/3). Three of the most pow-
erful carcinogens yielded a substantial number of
histidine positive revertants. The weak carcinogens
did not have any demonstrable effect on the strains
studied. As a consequence, the parallel effect be-
tween the carcinogenic and mutagenic action of
chemical compounds can serve as an indirect proof
of the mutagenic process of malignancy (51, 52).
The results of testing chemical carcinogens for
mutagenicity in various test systems show that
many, up to 80% (53) and even up to 90% (54), and
perhaps all of the chemical carcinogens are muta-
gens (55). In this respect, the study ofthe mutagenic
properties ofchemical carcinogens and in particular
of polycyclic aromatic hydrocarbons opens up a
great possibility to monitorthe spread ofsubstances
in the biosphere which are dangerous from the car-
cinogenic point of view.
From the point of view of practice, the use of
already studied genetic methods which define en-
vironmental mutagens will make it possible in a
short time by use of mass screening methods to de-
termine environmental pollutants which are harmful
from a carcinogenic point ofview and which would
otherwise require a great deal of time and labor to
determine by ordinary methods.
In its entirety, problems associated with the pre-
vention of environmental pollution by carcinogenic
substances should be solved by a complex of
June 1979 187means. Under these conditions, genetic methods
could play a decisive role in solving the individual
aspects of this problem.
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